New Triple-Threat attack on lung cancer before surgery
NCT ID NCT07286942
Summary
This study aims to see if a combination of targeted radiation, two immunotherapy drugs, and chemotherapy given before surgery can better eliminate cancer cells in patients with operable non-small cell lung cancer. The treatment is designed to shrink the tumor and prepare the immune system before the surgical removal. Researchers will measure how many patients have no detectable cancer left at surgery and monitor safety and long-term outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jiangsu Cancer Hospital
Nanjing, Jiangsu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.